Abstract
Radiotherapy has played a central role in the treatment of neoplasms since the discovery of X-rays, particularly with regard to organ preservation where mutilating procedures may be avoided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Herskovich AMK, al-Sarraf M, Leichman L (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of esophagus. N Engl J Med 326:1593–1598
Minsky BD (2006) Primary combined-modality therapy for esophageal cancer. Oncology (Williston Park) 20(5):497–505
Zhao KL, Wang Y, Shi XH (2003) Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma. World J Gastroenterol 9:1374–1376
Urba SG, Porringer MB, Turrisi A (2001) Randomized trial of pre-operative chemoradiation vs. surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313
Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of esophagus. N Engl J Med 337:161–167
Walsh TN, Noonan N, Hollywood D (1996) Comparison of multimodal therapy and surgery for esophageal carcinoma. N Engl J Med 335:462–467
Bonnetain F, Bouche O, Michel P (2006) A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 91029) Ann Oncol 17:827–834
Harvey JC, Fleishman EH, Bellotti JE (1993) Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs. low dose rate brachitherapy. J Surg Oncol 52:101–104
Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725
Zhang ZX, Gu XZ, Yin WB et al (1999) Ramdomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC). Report on 370 patients. Int J Radiat Oncol Biol Phys 44(5):1185
Ajani JA, Mansfield PF, Janjan N et al (2004) Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially respectable gastric carcinoma. J Clin Oncol 22:2774–2780
Gunderson L, Tepper J (2007) Clinical radiation oncology, 2nd edn. Churchill Livingstone Elsevier, Philadelphia
Abe M, Takahashi M, Ono K (1988) Japan gastric trials on intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 15(6): 1431–1433
Smalley SS, Gunderson L, Tepper J et al (2002) Gastric surgical adjuvant radiotherapy consensus report. Rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52:282
Pemberton L, Coote J, Perry V et al (2006) Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity. Clinical Oncology 18:663–668
Soyfer V, Corn BW, Melamud A et al (2007) Three-dimensional non-coplanar conformal radiotherapy yields better results than traditional beam arrangements for adjuvant treatment of gastric cancer. Int J Radiat Oncol Biol Phys 2:364–369
Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006–2010
Sohn TA, Yeo CJ, Cameron JL (2000) Resected adenocarcinoma of the pancreas — 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4(6):567–579
Regine WF, Winter KW, Abrams R et al (2006) RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol 24(Suppl 18):A-4007, 180s
Haddock MG, Swaminathan R, Foster NR et al (2007) Gemcitabine, cisplatin and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol 25:2567–2572
Morris SL, Beaslye M, Leslie M et al (2004) Chemotherapy for pancreatic cancer. N Engl J Med 350:2713
Regine WF, Winter KW, Abrams R et al (2006) RTOG 9704, a phase III study of adjuvant pre-and post-chemoradiation (CRS) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol 185:4007
Spitz FR, Abbruzzese JL, Lee JL (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15(3):928–937
Hoffmann JP, Cooper HS, Nancy A (1998) Preoperative chemoterapy of chemoradiotherapy of treatment of adenocarcinoma of the pancreas and ampulla of Vater. J Hepatobil Pancr Surg 5:251–252
Moertel CG, Frytak S, Hahn RG (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose radiation alone, moderate dose radiation and high dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group. Cancer 48:1705–1710
Oettle H, Neuhaus P (2007) Adjuvant therapy in pancreatic cancer: a critical appraisal. Drugs 67(16):2293–2310
Li CP, Chao Y, Chi KH et al (2003) Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine vs. 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys 57(1):98–104
Milano MT, Chmura SJ, Garafalo MC (2004) Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 59:445
Gastrointestinal Tumor Study Group (1984) Adjuvant therapy of colon cancer. Results of a prospectively randomized trial. N Engl J Med 312:1465
O’Connel MJ, Martenson JA, Wiland HS et al (1994) Improving adjuvant therapy for rectal cancer by combining protected infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507
O’Connell MJ (2002) Improving adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 20:1751–1758
Bosset JF (2004) Does the addition of chemotherapy to preoperative radiotherapy increase the pathological response in patients with resected rectal cancer? Proc ASCO 22:247
Sauer R, Becker H, Homenberger W et al (2004) Preoperative chemoradiotherapy as compared with postoperative chemoradiotherapy for locally advanced rectal cancer. New Engl J Med 351:11–20
Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303–312
Roedel C (2004) Tumor regression grade as a prognostic factor in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Radiat Oncol Biol Phis 60(1):S140
Bonnen M, Crane C, Vauthey JN et al (2004) Long term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60(4): 1098–1105
Larson SM, Schoder H, Yeung H (2004) Positron emission tomography / computerized tomography functional imaging of esophageal and colorectal cancer. Cancer J 10:243–250
Suzuki K, Dozois RR, Devine RM (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39(7):730–736
Valentini V, Morganti AG, De Franco A (1999) Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrence of rectal carcinoma: prognostic factors and long term outcome. Cancer 86(12):2612–2624
Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792–800
Nigro ND, Seydal HG, Considine B et al (1983) Combined preoperative radiation and chemotherapy for squamous-cell carcinoma of the anal canal. Cancer 51(10):1826–1829
Crehange G, Bosset M, Lorchel F et al (2006) Combining cisplatin and Mitomycin with radiotherapy in anal carcinoma. Dis Colon Rectum 50:43–49
Ajani JA, Winter KA, Gunderson LL et al (2006) Intergroup RTOG 98-11: a phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy vs. 5-FU cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 24: 18S, abstract 4009
Konski AA, Winter K, John M et al (2007) Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of Radiation Therapy Oncology Group (RTOG) 92-08. J Clin Oncol Gastrointestinal Cancers Symposium. Abstract 297
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Enrici, R.M., Osti, M.F., Berardi, F. (2009). The Radiotherapist’s Point of View. In: Surgery in Multimodal Management of Solid Tumors. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-1085-7_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-1085-7_6
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1084-0
Online ISBN: 978-88-470-1085-7
eBook Packages: MedicineMedicine (R0)